The New Jersey Commission on Science and Technology recently met at the Enterprise Development Center (EDC) at New Jersey Institute of Technology (NJIT). Prior to the meeting, commission members mingled with entrepreneurs and inventors from the New Jersey incubators, including the EDC program itself, which the commission supports through competitive grants. EDC entrepreneurs displaying their work included: Vincent Sette, executive vice president of business for Mail Call, Larry Gardner, chief executive officer of CyberExtruder, and Harvey Homan, chief executive officer of Urovalve.
Mail Call is a communication service that allows subscribers to listen or respond to email correspondence via a cell or land telephone. The calls are routed through a proprietary technology. The system is currently being marketed in Denver, Boston, San Diego, Los Angeles and San Francisco.
Cyber-Extruder is a young software development company which uses a core technology enabling the automatic conversions of 2-D facial images (such as passport photos) to life-like biometrically and forensically accurate 3-D models of the subjects' faces or heads. The technology has applications in the entertainment and security industries.
Urovalve, Inc, holds a patent on a silicone device to help male patients coping with urine retention who now must rely on catheters. The device would be implanted into the urethra during a simple procedure performed in a physician's office or by a nurse in a patient's home. It contains a metal valve which opens whenever the user wants. A pocket-sized magnetic wand carried by the user activates the device.
Since 1988, the EDC has helped inventors move innovative products out of the lab and into the marketplace. A high-tech business incubator housed in a trio of Newark buildings, the EDC provides office and lab space, financial help, business and technical services, and the shared expertise of the center's managers.
EDC is Page: 1 2 Related medicine news :1
Contact: Sheryl Weinstein
New Jersey Institute of Technology
. Meningitis: effectiveness of preventive vaccination demonstrated2
. Energy Up demonstrates success as obesity intervention program for inner-city girls3
. 12-month study demonstrated tolerability and efficacy of Daytrana4
. Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD5
. New study demonstrates that Lubiprostone may improve symptom relief rates in adults with IBS-C6
. Research demonstrates link between domestic violence and asthma7
. New study demonstrates nicotines role in smoking behavior8
. Preclinical results of Geovaxs AIDS vaccines demonstrate potential to protect against disease9
. Study demonstrates long-term durability of Plicator procedure10
. Penn researchers demonstrate ability of new therapy to treat severely elevated cholesterol levels11
. Circumcision for prevention of HIV: new analysis demonstrates cost-effectiveness